Welcome to our dedicated page for COMPOSECURE SEC filings (Ticker: CMPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CompoSecure, Inc. (CMPO) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, which document its evolution from a standalone issuer into part of a broader platform and detail its capital structure, governance, and financing arrangements. Filings such as Forms 8-K, Form 25, and registration-related documents capture material events, exchange listing changes, business combinations, and significant debt transactions.
For CompoSecure, recent 8-K filings describe the completion of its combination with Husky Technologies Limited, the rebranding of the corporate entity to GPGI, Inc., and the related issuance of cash and shares of Class A common stock as transaction consideration. These filings also outline associated agreements, including an Investor Rights Agreement and a Registration Rights Agreement with an affiliate of Platinum Equity, and a management agreement with Resolute Holdings Management, Inc. for the Husky business. Together, they provide detail on board nomination rights, registration rights, and management fee structures tied to adjusted EBITDA at a Husky holding entity.
Additional 8-Ks and related exhibits cover CompoSecure’s capital markets actions, such as the call for redemption of public warrants trading under CMPOW, the transfer of its Class A common stock listing to the New York Stock Exchange, and a large refinancing completed after the Husky transaction. The refinancing disclosure explains a private placement of senior secured notes due 2033, a new term loan facility maturing in 2033, and revolving credit commitments maturing in 2031, along with the use of proceeds to refinance existing indebtedness and pay related fees and expenses. A Form 25 filing documents the removal from listing and/or registration of a class of warrants from the Nasdaq Stock Market LLC.
Investors can use these filings to understand CompoSecure’s debt profile, covenant structures, and leverage, as well as to review non-GAAP metrics and management’s discussion of performance that appear in earnings-related 8-Ks and attached presentations. The filings also provide formal records of shareholder approvals for the Husky business combination and related equity issuances, along with disclosures about litigation and supplemental proxy information.
On Stock Titan, CompoSecure’s SEC filings are updated as new documents are posted to EDGAR, and AI-powered summaries can help explain the key points in lengthy agreements, financing descriptions, and transaction narratives. This makes it easier to locate information on topics such as the Husky transaction terms, the GPGI rebranding, warrant redemption mechanics, and the structure of CompoSecure’s senior secured notes and credit facilities without reading every page of each filing.
Amanda "Mandy" Gourbault, Chief Revenue Officer of CompoSecure, Inc. (CMPO), reported an open-market sale of 85,365 shares of Class A Common Stock on 08/13/2025 at a weighted average price of $19.02 per share. After the sale she beneficially owned 799,668 shares on a direct basis. The reported holdings include 218,960 shares currently owned outright and a mix of restricted stock units (RSUs) and performance-vesting RSUs that vest on specified future dates: time-based RSUs vesting through 2032 and 291,670 performance RSUs vesting based on achievement of performance targets. The Form 4 was signed on 08/14/2025 by attorney-in-fact Steven J. Feder.
CompoSecure, Inc. is reported to have an aggregate of 8,726,591 shares of Class A Common Stock beneficially owned by the LMR reporting group, representing approximately 7.9% of the Class A shares outstanding. The position arises from exercisable warrants held directly by LMR Multi-Strategy Master Fund Limited (4,313,014 warrants) and LMR CCSA Master Fund Ltd (4,413,577 warrants), giving the reporting persons shared voting and dispositive power over the aggregate amount while showing 0 shares of sole voting or sole dispositive power.
The filing identifies the reporting persons as a set of LMR investment managers and two individuals, Ben Levine and Stefan Renold, across multiple jurisdictions, and states that the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The 7.9% figure is calculated using an issuer share count of 102,357,732 Class A shares as reported by the issuer.
Locust Wood and affiliated entities disclosed beneficial ownership of 8,259,527 shares of CompoSecure, Inc. Class A common stock, representing approximately 8.1% of the 102,317,852 shares outstanding referenced in the filing. The aggregate position reflects holdings across Locust Wood Capital, Locust Wood Ultra Fund and certain client accounts managed by Locust Wood Capital Advisers.
The filing provides specific reported holdings: Locust Wood Capital holds 2,075,000 shares, Locust Wood Ultra Fund holds 520,939 shares, and the filing identifies 3,463,068 shares held in certain Managed Accounts. The filing also states that Locust Wood Capital Advisers, LWCA, LWCA GP and Stephen Errico may be deemed to beneficially own 5,663,588 shares. The statement affirms the securities were not acquired to change or influence control of the issuer.
CompoSecure, Inc. reports a proposed sale under Rule 144 of 85,365 shares of Class A common stock, with an aggregate market value of $1,623,274.14. The shares were acquired on 01/01/2025 through the vesting of a restricted stock unit award granted under the issuers equity compensation plan. The planned disposition will be executed through Merrill Lynch on NASDAQ with an approximate sale date listed as 08/13/2025.
The filing states there were no securities sold by the filer in the past three months and includes the filers representation that they are not aware of any undisclosed material adverse information about the issuer. The notice also references Rule 10b5-1 trading plans but does not indicate that a plan was adopted.
CompoSecure, Inc. (CMPO) filed a Form 144 notice for a proposed sale of 19,899 shares of Class A common stock on the NASDAQ through Merrill Lynch, with an aggregate market value of $383,293.75 and 102,378,638 shares outstanding. The shares were acquired and paid for on 08/13/2025 by exercise of employee stock options in a broker-assisted exercise. The filing reports "Nothing to Report" for sales in the past three months. The document does not provide the name of the selling person or identifying filer details in the visible content.
Kevin M. Moriarty, identified in the filing as a director of CompoSecure, Inc. (CMPO), purchased 13,000 shares of Class A common stock on 08/13/2025 at a weighted average price of $19.28 per share. The Form 4 reports the purchases were made in multiple transactions at prices ranging from $19.10 to $19.30, and the reporting person holds 13,000 shares following these trades. The filing was submitted by a single reporting person and records the holdings as direct beneficial ownership. No derivative securities are listed in the report, and the filer states they will provide a per-price breakdown on request.
Timothy W. Fitzsimmons, Chief Financial Officer of CompoSecure, reported the sale of 100,000 shares of Class A Common Stock on 08/12/2025 for a weighted-average price of $18.74. Following that sale he beneficially owns 759,789 shares.
His reported holdings combine 323,378 directly owned shares and multiple restricted stock unit (RSU) tranches: 48,071 RSUs vesting in three equal installments on February 26, 2028, 2030 and 2032; 62,500 RSUs vesting January 1, 2026; 30,561 RSUs vesting January 1, 2026; 81,438 RSUs vesting ratably on January 1, 2026 and January 1, 2027; plus 213,841 performance-vesting RSUs that vest only if performance targets are met. RSUs will be settled into Class A Common Stock and may be net-settled to cover taxes.
Form 144/A notice documents a proposed sale of 100,000 common shares through Edward Jones with an aggregate market value of $1,796,000.00 and an indicated trading venue of Nasdaq. The filing lists 102,317,852 shares outstanding and an approximate sale date of 08/12/2025. The securities to be sold were acquired as restricted stock units: 62,500 vested on 01/01/2023 and 37,500 vested on 01/01/2024, both shown as vesting from Composecure Inc. The form reports "Nothing to Report" for sales in the past three months and includes the standard signature representation about absence of undisclosed material adverse information. Several administrative fields (filer and issuer name/details and signature/date) are not populated in the visible content.
CompoSecure, Inc. filed a Form 144 reporting a proposed sale of 1,000 shares of common stock through Edward Jones (201 Progress Parkway, Maryland Heights, MO). The filing lists an aggregate market value of $17,960, states 102,317,852 shares outstanding, and gives an approximate date of sale of 08/12/2025 with the exchange listed as "Nadaq."
The securities were acquired via RSU vesting on 01/01/2023 (62,500 shares) and 01/01/2024 (37,500 shares). The filer certifies they do not know of undisclosed material adverse information and reports nothing to report for securities sold in the past three months.
Q2-25 10-Q highlights (post spin-off & equity-method shift)
On 28-Feb-25 CompoSecure (CMPO) spun off Resolute Holdings and ceded control of operating subsidiary CompoSecure Holdings, L.L.C. (“Holdings”). Holdings is now carried as an equity-method investment. As a result, CMPO no longer records revenue or cost of sales; instead it reports its share of Holdings’ profit.
Income statement: For the quarter ended 30-Jun-25 CMPO booked $38.9 m of equity-method earnings, offset by non-cash fair-value losses on warrants (-$53.4 m) and earn-out liabilities (-$10.7 m). SG&A was $2.7 m. Net loss attributable to CMPO was -$26.1 m (-$0.26 per share) versus $33.6 m profit a year earlier.
Balance sheet: Deconsolidation shrank assets to $317 m from $474 m at 31-Dec-24. Cash fell sharply to $4.8 m. A $44.7 m equity-method asset was recognized. Liabilities declined to $424 m but still exceed assets, leaving a stockholders’ deficit of $106 m. Warrant liability expanded to $137.4 m.
Cash flow & liquidity: Operating cash inflow was $3.0 m YTD; $60.7 m was used in investing, mainly removal of Holdings’ cash. Financing outflow was $15.0 m. Net cash burn of $72.7 m heightens liquidity risk; CMPO depends on distributions from Holdings.
- 102.4 m Class A shares outstanding; dual-class structure eliminated.
- Deferred tax asset stands at $266.7 m.
Key takeaway: Equity-method profits remain solid, but parent-level cash is thin and non-cash mark-to-market items drive volatile GAAP results.